Kathryn J Ruddy Selected Research

Amenorrhea

1/2022	Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions.
8/2021	Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
7/2021	Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer.
1/2021	Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea.
10/2019	Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.
1/2019	Amenorrhea after lung cancer treatment.
6/2015	Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
8/2014	Treatment-related amenorrhea and sexual functioning in young breast cancer survivors.
4/2014	Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.
12/2007	Fertility and adjuvant treatment in young women with breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathryn J Ruddy Research Topics

Disease

63	Breast Neoplasms (Breast Cancer) 02/2022 - 12/2007
44	Neoplasms (Cancer) 03/2022 - 04/2013
14	Peripheral Nervous System Diseases (PNS Diseases) 09/2021 - 11/2014
10	Amenorrhea 01/2022 - 12/2007
6	Nausea 01/2021 - 07/2016
6	Pain (Aches) 01/2021 - 01/2016
6	Vomiting 01/2021 - 07/2016
5	Infertility (Sterility) 08/2021 - 12/2007
4	Male Breast Neoplasms (Male Breast Cancer) 08/2022 - 01/2015
4	Hot Flashes 02/2020 - 10/2012
4	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2017
4	Fatigue 01/2019 - 07/2017
3	Cardiotoxicity 02/2022 - 09/2017
3	Heart Failure 01/2020 - 04/2017
2	Disease Progression 12/2021 - 10/2015
2	Chronic Disease (Chronic Diseases) 11/2019 - 01/2018
2	Lymphedema (Milroy Disease) 01/2019 - 10/2018
2	Acute Pain 11/2017 - 02/2016
2	Hypesthesia (Numbness) 11/2017 - 02/2016
1	Left Ventricular Dysfunction 02/2022
1	Premature Birth (Birth, Premature) 10/2021
1	Premature Menopause 08/2021
1	Breast Diseases (Breast Disease) 03/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Alopecia (Baldness) 12/2020
1	Abdominal Pain (Pain, Abdominal) 02/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Hypopituitarism (Sheehan's Syndrome) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 06/2019
1	Cognitive Dysfunction 01/2019
1	Musculoskeletal Pain 01/2019
1	Infections 01/2019

Drug/Important Bio-Agent (IBA)

14	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 04/2014
13	Hormones (Hormone)IBA 01/2022 - 12/2007
8	Estrogen ReceptorsIBA 07/2021 - 01/2017
5	Trastuzumab (Herceptin)FDA Link 02/2022 - 06/2015
5	Biological ProductsIBA 01/2022 - 12/2007
5	Tamoxifen FDA LinkGeneric 01/2020 - 06/2012
4	Aromatase InhibitorsIBA 01/2022 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 04/2014
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2021 - 10/2015
3	Phenobarbital (Luminal)FDA Link 01/2022 - 04/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2014
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 10/2019
3	AnthracyclinesIBA 07/2021 - 10/2018
3	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 11/2017
2	Ado-Trastuzumab EmtansineIBA 02/2022 - 08/2021
2	PlatinumIBA 01/2022 - 03/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2021 - 01/2020
2	Anti-Mullerian HormoneIBA 01/2021 - 04/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2020 - 11/2014
2	Estrogens (Estrogen)FDA Link 02/2020 - 01/2016
2	AntiemeticsIBA 01/2020 - 01/2020
2	human ERBB2 proteinIBA 01/2020 - 09/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 04/2014
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2013 - 06/2012
2	4-hydroxy-N-desmethyltamoxifenIBA 10/2013 - 06/2012
1	mahuang-tangIBA 01/2022
1	oleyloxyethylphosphorylcholineIBA 12/2021
1	Galectin 3 (LGALS3)IBA 07/2021
1	pro-brain natriuretic peptide (1-76)IBA 07/2021
1	taxaneIBA 03/2021
1	Taxoids (Taxanes)IBA 03/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Opiate AlkaloidsIBA 01/2021
1	oxybutynin (Tavor)FDA LinkGeneric 02/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020
1	IpilimumabIBA 01/2020
1	Folate Receptor 1IBA 01/2020
1	IceIBA 12/2019
1	olaparibIBA 10/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	prolyl-proline (Pro-Pro)IBA 05/2018
1	lipid-associated sialic acid (LASA)IBA 05/2018

Therapy/Procedure

46	Drug Therapy (Chemotherapy) 01/2022 - 12/2007
36	Therapeutics 03/2022 - 01/2009
9	Aftercare (After-Treatment) 08/2022 - 12/2007
6	Radiotherapy 10/2021 - 11/2016
4	Segmental Mastectomy (Lumpectomy) 01/2022 - 11/2015
4	Mastectomy (Mammectomy) 10/2021 - 11/2015
4	Adjuvant Chemotherapy 02/2021 - 01/2011
3	Neoadjuvant Therapy 02/2022 - 02/2021
1	Cesarean Section (Caesarean Section) 10/2021
1	Mammaplasty (Breast Reconstruction) 10/2021
1	Occupational Therapy (Therapy, Occupational) 01/2021
1	Continuity of Patient Care 01/2021
1	Meditation 01/2021
1	Psychotherapy Imagery (Guided Imagery) 01/2021
1	Complementary Therapies (Alternative Medicine) 12/2020
1	Contraindications 01/2020
1	Simple Mastectomy 01/2020
1	Cryotherapy (Therapy, Cold) 12/2019
1	Ovariectomy (Oophorectomy) 01/2019
1	Brachytherapy 01/2019
1	Immunotherapy 01/2019